Bilha Stefana Catalina, Matei Anca, Branisteanu Dumitru D, Teodoriu Laura Claudia, Hristov Ioana, Bilha Stefan, Leustean Letitia, Ungureanu Maria-Christina, Apostol Ciobanu Delia Gabriela, Preda Cristina, Velicescu Cristian
Endocrinology Department, "St. Spiridon" Emergency Hospital, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Department of Medicine, Charles E. Smith College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, USA.
Diagnostics (Basel). 2024 May 29;14(11):1127. doi: 10.3390/diagnostics14111127.
Parathyroid carcinoma (PC) associated with primary hyperparathyroidism (PHPT) has been well investigated in recent years. Data regarding PC evolution in secondary hyperparathyroidism (SHPT) due to chronic kidney disease (CKD) are, however, scarce. Most features that raise the suspicion of PC in PHPT are part of the usual SHPT evolution in CKD, mirroring the natural changes undergone by the parathyroid glands. Therefore, pre-surgically establishing the malignant or benign character of the lesions is cumbersome. We present two cases of PC in end-stage renal disease, one of which was bilateral, diagnosed after total parathyroidectomy in a high-volume parathyroid surgery center. A literature review of the data was also performed. A systematic search of the PubMed/MEDLINE database until January 2024 identified 42 cases of PC associated with SHPT. Understanding the PC features in CKD might improve associated bone and mineral disease management, and reduce the risk of metastasis, parathyromatosis, or recurrence. Irradiation, prolonged immunosuppression, long dialysis vintage, and genotype may predispose to the malignant transformation of chronically stimulated parathyroids. Despite postsurgical diagnosis, favorable outcomes occurred when distant metastases were absent, even without "en bloc" resection. Further research is warranted to delineate specific diagnostic and therapeutic approaches tailored to this particular patient subpopulation.
近年来,对与原发性甲状旁腺功能亢进症(PHPT)相关的甲状旁腺癌(PC)已进行了充分研究。然而,关于慢性肾脏病(CKD)所致继发性甲状旁腺功能亢进症(SHPT)中PC演变的数据却很稀少。在PHPT中引发对PC怀疑的大多数特征都是CKD中常见的SHPT演变的一部分,反映了甲状旁腺所经历的自然变化。因此,术前确定病变的恶性或良性性质很麻烦。我们报告了两例终末期肾病中的PC病例,其中一例为双侧病变,在一家大型甲状旁腺手术中心进行甲状旁腺全切术后确诊。我们还对相关数据进行了文献综述。对PubMed/MEDLINE数据库进行系统检索直至2024年1月,共识别出42例与SHPT相关的PC病例。了解CKD中的PC特征可能会改善相关的骨和矿物质疾病管理,并降低转移、甲状旁腺瘤病或复发的风险。放疗、长期免疫抑制、长期透析史和基因型可能会使长期受刺激的甲状旁腺发生恶性转化。尽管是术后诊断,但在没有远处转移的情况下,即使没有“整块”切除,也会出现良好的预后。有必要进行进一步研究,以确定针对这一特定患者亚群的具体诊断和治疗方法。